v3.26.3
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]    
Revenue $ 6,120 $ 7,894
Cost of revenue 76,820 177,279
Gross profit (70,700) (169,385)
Operating expenses:    
Research and development 11,016 103,322
General and administrative 2,730,281 3,306,299
Impairment loss 501,118 1,130,000
Total operating expenses 3,242,415 4,539,621
Loss from operations (3,313,115) (4,709,006)
Other income (expense):    
Interest expense (24,068) (4,765)
Loss on settlement of liabilities (2,500) 0
Other income 24,493 225
Total other income (expense) (2,075) (4,540)
Net loss (3,315,190) (4,713,546)
Noncontrolling interest (40,068) (45,512)
Net loss attributable to GenFlat Holdings, Inc. $ (3,275,122) $ (4,668,034)
Loss per share - basic attributable to GenFlat Holdings, Inc $ (0.28) $ (0.44)
Loss per share - diluted attributable to GenFlat Holdings, Inc (0.28) (0.44)
Loss per share - basic attributable to noncontrolling interest. (0.00) (0.00)
Loss per share - diluted attributable to noncontrolling interest. $ (0.00) $ (0.00)
Weighted average common shares outstanding - basic 11,697,555 10,651,990
Weighted average common shares outstanding - diluted 11,697,555 10,651,990